Bavarian Nordic cannot exclusively handle production of the company's covid-19 vaccine if and when it is ready for phase III and the subsequent commercialization.
In spite of expansions made in the firm's production apparatus in recent years, the firm lacks the equipment and capacity necessary for fulfilling production in this scale, which Bavarian Nordic Chief Financial Officer Henrik Juuel tells MedWatch in an interview.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Medical Scientific Liaison Dermo aesthetic, IBSA 
Senior Clinical Research Specialist - Ambu 
Analytical Coordinator - Symphogen 
Associate Director/Senior Manager, Global Regulatory Affairs Project Lead - Genmab 
Evaxion Biotech Careers 
QA Specialist wanted 
Employee of the regulatory department with knowledge of food safety and legislation within dietary supplements and medicines 
A tech-savvy Project Manager Oncology (m/f/x) with a passion for communication and cross-functional collaboration - Daiichi-Sankyo 
Scientific Advisor infectious disease - Vaccibody 
Project Manager, Adcendo ApS 
KLIFO is looking for a talented Medical Writer (DK, SE or DE) 
Senior Drug Product Specialist - Zealand Pharma 
Associate Director, PV QA - Y-mAbs Therapeutics 
Global Senior Medical Advisor – Neurology Pipeline Projects, Lundbeck